Bone Marrow TransplantationTransplantation, HomologousBone MarrowGraft vs Host DiseaseTransplantation ConditioningHematopoietic Stem Cell TransplantationTransplantation ChimeraBone Marrow CellsTransplantation, AutologousWhole-Body IrradiationLiver TransplantationHistocompatibilityGraft SurvivalTissue DonorsHistocompatibility TestingHematologic NeoplasmsLeukemiaKidney TransplantationBone and BonesBusulfanStem Cell TransplantationImmunosuppressive AgentsAnemia, AplasticGraft RejectionMyeloablative AgonistsTreatment OutcomeLymphocyte DepletionCyclophosphamideHLA AntigensTransplantation ImmunologyRecurrenceHeart TransplantationSevere Combined ImmunodeficiencyTransplantation, IsogeneicHematopoietic Stem CellsLymphocyte TransfusionBone Marrow PurgingVidarabineGraft vs Leukemia EffectLung TransplantationRemission InductionGraft vs Tumor EffectCord Blood Stem Cell TransplantationT-LymphocytesCombined Modality TherapyPeripheral Blood Stem Cell TransplantationRadiation ChimeraLeukemia, Myeloid, AcuteMice, Inbred C57BLImmunosuppressionTime FactorsBone Marrow DiseasesOrgan TransplantationHematopoiesisCyclosporineRetrospective StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseSurvival AnalysisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphoma, Non-HodgkinAntilymphocyte SerumBone Marrow ExaminationHepatic Veno-Occlusive DiseaseLiving DonorsSurvival RateDisease-Free SurvivalHost vs Graft ReactionFollow-Up StudiesPancreas TransplantationGraft vs Host ReactionHaploidyLeukemia, MyeloidSkin TransplantationBone RemodelingIslets of Langerhans TransplantationTransplantation ToleranceCell TransplantationBone Marrow NeoplasmsChimerismLeukocyte TransfusionTransplantationHaplotypesChimeraNuclear FamilyMultiple MyelomaMyelodysplastic SyndromesMelphalanAntineoplastic Combined Chemotherapy ProtocolsColony-Forming Units AssayGranulocyte Colony-Stimulating FactorActuarial AnalysisAntigens, CD34Mice, Inbred BALB CHematologic DiseasesImmune ToleranceSiblingsLeukocyte CountCytomegalovirus InfectionsCell Differentiation